1. Mapp PI, Sagar DR, Ashraf S, Burston JJ, Suri S, Chapman V, Walsh DA: Differences in structural and pain phenotypes in the sodium monoiodoacetate and meniscal transection models of osteoarthritis. Osteoarthritis Cartilage 2013, 21(9):1336-1345.
2. Fu K, Robbins SR, McDougall JJ: Osteoarthritis: the genesis of pain. Rheumatology (Oxford) 2018, 57(suppl_4):iv43-iv50.
3. Thakur M, Rahman W, Hobbs C, Dickenson AH, Bennett DL: Characterisation of a peripheral neuropathic component of the rat monoiodoacetate model of osteoarthritis. PLoS One 2012, 7(3):e33730.
4. Syx D, Tran PB, Miller RE, Malfait AM: Peripheral Mechanisms Contributing to Osteoarthritis Pain. Curr Rheumatol Rep 2018, 20(2):9.
5. Hunter DJ, McDougall JJ, Keefe FJ: The symptoms of osteoarthritis and the genesis of pain. Med Clin North Am 2009, 93(1):83-100, xi.
6. Power JD, Perruccio AV, Gandhi R, Veillette C, Davey JR, Syed K, Mahomed NN, Rampersaud YR: Neuropathic pain in end-stage hip and knee osteoarthritis: differential associations with patient-reported pain at rest and pain on activity. Osteoarthritis Cartilage 2018, 26(3):363-369.
7. French HP, Smart KM, Doyle F: Prevalence of neuropathic pain in knee or hip osteoarthritis: A systematic review and meta-analysis. Semin Arthritis Rheum 2017, 47(1):1-8.
8. Zolio L, Lim KY, McKenzie JE, Yan MK, Estee M, Hussain SM, Cicuttini F, Wluka A: Systematic review and meta-analysis of the prevalence of neuropathic-like pain and/or pain sensitization in people with knee and hip osteoarthritis. Osteoarthritis Cartilage 2021, 29(8):1096-1116.
9. Wylde V, Beswick A, Bruce J, Blom A, Howells N, Gooberman-Hill R: Chronic pain after total knee arthroplasty. EFORT Open Rev 2018, 3(8):461-470.
10. Thakur M, Dickenson AH, Baron R: Osteoarthritis pain: nociceptive or neuropathic? Nature reviews Rheumatology 2014, 10(6):374-380.
11. Orita S, Ishikawa T, Miyagi M, Ochiai N, Inoue G, Eguchi Y, Kamoda H, Arai G, Toyone T, Aoki Y et al: Pain-related sensory innervation in monoiodoacetate-induced osteoarthritis in rat knees that gradually develops neuronal injury in addition to inflammatory pain. BMC Musculoskelet Disord 2011, 12:134.
12. Wu Q, Henry JL: Changes in Abeta non-nociceptive primary sensory neurons in a rat model of osteoarthritis pain. Molecular pain 2010, 6:37.
13. Kelly S, Dunham JP, Murray F, Read S, Donaldson LF, Lawson SN: Spontaneous firing in C-fibers and increased mechanical sensitivity in A-fibers of knee joint-associated mechanoreceptive primary afferent neurones during MIA-induced osteoarthritis in the rat. Osteoarthritis Cartilage 2012, 20(4):305-313.
14. Raoof R, Martin Gil C, Lafeber F, de Visser H, Prado J, Versteeg S, Pascha MN, Heinemans ALP, Adolfs Y, Pasterkamp J et al: Dorsal Root Ganglia Macrophages Maintain Osteoarthritis Pain. J Neurosci 2021, 41(39):8249-8261.
15. Zhuo M, Wu G, Wu LJ: Neuronal and microglial mechanisms of neuropathic pain. Mol Brain 2011, 4:31.
16. Shin SM, Cai Y, Itson-Zoske B, Qiu C, Hao X, Xiang H, Hogan QH, Yu H: Enhanced T-type calcium channel 3.2 activity in sensory neurons contributes to neuropathic-like pain of monosodium iodoacetate-induced knee osteoarthritis. Molecular pain 2020, 16:1744806920963807.
17. Schuelert N, McDougall JJ: Involvement of Nav 1.8 sodium ion channels in the transduction of mechanical pain in a rodent model of osteoarthritis. Arthritis Res Ther 2012, 14(1):R5.
18. Bourinet E, Francois A, Laffray S: T-type calcium channels in neuropathic pain. Pain 2016, 157 Suppl 1:S15-22.
19. Srinivasan PP, Parajuli A, Price C, Wang L, Duncan RL, Kirn-Safran CB: Inhibition of T-Type Voltage Sensitive Calcium Channel Reduces Load-Induced OA in Mice and Suppresses the Catabolic Effect of Bone Mechanical Stress on Chondrocytes. PLoS One 2015, 10(5):e0127290.
20. Shin SM, Lauzadis J, Itson-Zoske B, Cai Y, Fan F, Natarajan G, Kwok WM, Puopolo M, Hogan QH, Yu H: Targeting intrinsically disordered regions facilitates discovery of CaV3.2 inhibitory peptides for AAV-mediated peripheral analgesia. Pain 2022, PMID: 35420557 DOI: 10.1097/j.pain.0000000000002650.
21. Im HJ, Kim JS, Li X, Kotwal N, Sumner DR, van Wijnen AJ, Davis FJ, Yan D, Levine B, Henry JL et al: Alteration of sensory neurons and spinal response to an experimental osteoarthritis pain model. Arthritis Rheum 2010, 62(10):2995-3005.
22. Fischer G, Kostic S, Nakai H, Park F, Sapunar D, Yu H, Hogan Q: Direct injection into the dorsal root ganglion: technical, behavioral, and histological observations. Journal of neuroscience methods 2011, 199(1):43-55.
23. Bove SE, Calcaterra SL, Brooker RM, Huber CM, Guzman RE, Juneau PL, Schrier DJ, Kilgore KS: Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. Osteoarthritis Cartilage 2003, 11(11):821-830.
24. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. Journal of neuroscience methods 1994, 53(1):55-63.
25. Wu HE, Gemes G, Zoga V, Kawano T, Hogan QH: Learned avoidance from noxious mechanical simulation but not threshold semmes weinstein filament stimulation after nerve injury in rats. J Pain 2010, 11(3):280-286.
26. Pan B, Yu H, Park J, Yu YP, Luo ZD, Hogan QH: Painful nerve injury upregulates thrombospondin-4 expression in dorsal root ganglia. J Neurosci Res 2015, 93(3):443-453.
27. Juarez-Salinas DL, Braz JM, Etlin A, Gee S, Sohal V, Basbaum AI: GABAergic cell transplants in the anterior cingulate cortex reduce neuropathic pain aversiveness. Brain 2019, 142(9):2655-2669.
28. Juarez-Salinas DL, Braz JM, Hamel KA, Basbaum AI: Pain relief by supraspinal gabapentin requires descending noradrenergic inhibitory controls. Pain Rep 2018, 3(4):e659.
29. Prus AJ, James JR, Rosecrans JA: Conditioned Place Preference. In: Methods of Behavior Analysis in Neuroscience. Edited by nd, Buccafusco JJ. Boca Raton (FL); 2009.
30. Park HJ, Sandor K, McQueen J, Woller SA, Svensson CI, Corr M, Yaksh TL: The effect of gabapentin and ketorolac on allodynia and conditioned place preference in antibody-induced inflammation. Eur J Pain 2016, 20(6):917-925.
31. Yu H, Fischer G, Ferhatovic L, Fan F, Light AR, Weihrauch D, Sapunar D, Nakai H, Park F, Hogan QH: Intraganglionic AAV6 Results in Efficient and Long-Term Gene Transfer to Peripheral Sensory Nervous System in Adult Rats. PLoS One 2013, 8(4):e61266.
32. Shin SM, Lauzadis J, Itson-Zoske B, Cai YS, Fan F, G N, Kwok WM, Puopolo M, Hogan GH, H. Y: Targeting intrinsically disordered regions facilitates discovery of CaV3.2 inhibitory peptides for AAV-mediated peripheral analgesia. PAIN (accepted) 2022, 10.1097/j.pain.0000000000002650.
33. Joksimovic SL, Joksimovic SM, Tesic V, Garcia-Caballero A, Feseha S, Zamponi GW, Jevtovic-Todorovic V, Todorovic SM: Selective inhibition of CaV3.2 channels reverses hyperexcitability of peripheral nociceptors and alleviates postsurgical pain. Sci Signal 2018, 11(545).
34. Cai W, Zhao Q, Shao J, Zhang J, Li L, Ren X, Su S, Bai Q, Li M, Chen X et al: MicroRNA-182 Alleviates Neuropathic Pain by Regulating Nav1.7 Following Spared Nerve Injury in Rats. Sci Rep 2018, 8(1):16750.
35. McCallum JB, Kwok WM, Sapunar D, Fuchs A, Hogan QH: Painful peripheral nerve injury decreases calcium current in axotomized sensory neurons. Anesthesiology 2006, 105(1):160-168.
36. Ivanavicius SP, Ball AD, Heapy CG, Westwood FR, Murray F, Read SJ: Structural pathology in a rodent model of osteoarthritis is associated with neuropathic pain: increased expression of ATF-3 and pharmacological characterisation. Pain 2007, 128(3):272-282.
37. Okun A, Liu P, Davis P, Ren J, Remeniuk B, Brion T, Ossipov MH, Xie J, Dussor GO, King T et al: Afferent drive elicits ongoing pain in a model of advanced osteoarthritis. Pain 2012, 153(4):924-933.
38. Pan B, Yu H, Fischer GJ, Kramer JM, Hogan QH: Dorsal Root Ganglionic Field Stimulation Relieves Spontaneous and Induced Neuropathic Pain in Rats. J Pain 2016, 17(12):1349-1358.
39. Mogil JS: Sex differences in pain and pain inhibition: multiple explanations of a controversial phenomenon. Nat Rev Neurosci 2012, 13(12):859-866.
40. Kim YS, Anderson M, Park K, Zheng Q, Agarwal A, Gong C, Saijilafu, Young L, He S, LaVinka PC et al: Coupled Activation of Primary Sensory Neurons Contributes to Chronic Pain. Neuron 2016, 91(5):1085-1096.
41. Shin SM, Itson-Zoske B, Cai Y, Qiu C, Pan B, Stucky CL, Hogan QH, Yu H: Satellite glial cells in sensory ganglia express functional transient receptor potential ankyrin 1 that is sensitized in neuropathic and inflammatory pain. Mol Pain 2020, 16:1744806920925425.
42. He BH, Christin M, Mouchbahani-Constance S, Davidova A, Sharif-Naeini R: Mechanosensitive ion channels in articular nociceptors drive mechanical allodynia in osteoarthritis. Osteoarthritis Cartilage 2017, 25(12):2091-2099.
43. Soga M, Izumi T, Nanchi I, Horita N, Yamamoto M, Kawasaki S, Ogawa K, Fujita M, Morioka Y: Suppression of joint pain in transient receptor potential vanilloid 4 knockout rats with monoiodoacetate-induced osteoarthritis. Pain Rep 2021, 6(3):e951.
44. Koopmeiners AS, Mueller S, Kramer J, Hogan QH: Effect of electrical field stimulation on dorsal root ganglion neuronal function. Neuromodulation 2013, 16(4):304-311; discussion 310-301.
45. Yu G, Segel I, Zhang Z, Hogan QH, Pan B: Dorsal Root Ganglion Stimulation Alleviates Pain-related Behaviors in Rats with Nerve Injury and Osteoarthritis. Anesthesiology 2020, 133(2):408-425.
46. Na HS, Choi S, Kim J, Park J, Shin HS: Attenuated neuropathic pain in Cav3.1 null mice. Mol Cells 2008, 25(2):242-246.
47. Kidd BL: Osteoarthritis and joint pain. Pain 2006, 123(1-2):6-9.
48. Alves CJ, Couto M, Sousa DM, Magalhaes A, Neto E, Leitao L, Conceicao F, Monteiro AC, Ribeiro-da-Silva M, Lamghari M: Nociceptive mechanisms driving pain in a post-traumatic osteoarthritis mouse model. Sci Rep 2020, 10(1):15271.
49. Haywood AR, Hathway GJ, Chapman V: Differential contributions of peripheral and central mechanisms to pain in a rodent model of osteoarthritis. Sci Rep 2018, 8(1):7122.
50. Qu L, Caterina MJ: Enhanced excitability and suppression of A-type K(+) currents in joint sensory neurons in a murine model of antigen-induced arthritis. Sci Rep 2016, 6:28899.
51. Kwok CHT, Kohro Y, Mousseau M, O'Brien MS, Matyas JR, McDougall JJ, Trang T: Role of Primary Afferents in Arthritis Induced Spinal Microglial Reactivity. Front Immunol 2021, 12:626884.
52. Mousseau M, Burma NE, Lee KY, Leduc-Pessah H, Kwok CHT, Reid AR, O'Brien M, Sagalajev B, Stratton JA, Patrick N et al: Microglial pannexin-1 channel activation is a spinal determinant of joint pain. Sci Adv 2018, 4(8):eaas9846.
53. Tran PB, Miller RE, Ishihara S, Miller RJ, Malfait AM: Spinal microglial activation in a murine surgical model of knee osteoarthritis. Osteoarthritis Cartilage 2017, 25(5):718-726.
54. Miller RE, Tran PB, Ishihara S, Syx D, Ren D, Miller RJ, Valdes AM, Malfait AM: Microarray analyses of the dorsal root ganglia support a role for innate neuro-immune pathways in persistent pain in experimental osteoarthritis. Osteoarthritis Cartilage 2020, 28(5):581-592.
55. Rahman W, Dickenson AH: Osteoarthritis-dependent changes in antinociceptive action of Nav1.7 and Nav1.8 sodium channel blockers: An in vivo electrophysiological study in the rat. Neuroscience 2015, 295:103-116.
56. Goncalves WA, Rezende BM, de Oliveira MPE, Ribeiro LS, Fattori V, da Silva WN, Prazeres P, Queiroz-Junior CM, Santana KTO, Costa WC et al: Sensory Ganglia-Specific TNF Expression Is Associated With Persistent Nociception After Resolution of Inflammation. Front Immunol 2019, 10:3120.
57. Amir R, Devor M: Chemically mediated cross-excitation in rat dorsal root ganglia. J Neurosci 1996, 16(15):4733-4741.
58. Geraghty T, Winter DR, Miller RJ, Miller RE, Malfait AM: Neuroimmune interactions and osteoarthritis pain: focus on macrophages. Pain Rep 2021, 6(1):e892.
59. Raoof R, Martin Gil C, Lafeber F, de Visser HM, Prado J, Versteeg S, Pascha MN, Heinemans ALP, Adolfs Y, Pasterkamp RJ et al: Dorsal root ganglia macrophages maintain osteoarthritis pain. J Neurosci 2021.
60. Obeidat AM, Wood MJ, Ishihara S, Li J, Wang L, Ren D, Bennett DA, Miller RJ, Malfait AM, Miller RE: Piezo2 expressing nociceptors mediate mechanical sensitization in experimental osteoarthritis. bioRxiv 2022; doi: https://doiorg/101101/20220312484097 2022.
61. Wallace M, Duan R, Liu W, Locke C, Nothaft W: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the T-Type Calcium Channel Blocker ABT-639 in an Intradermal Capsaicin Experimental Pain Model in Healthy Adults. Pain Med 2016, 17(3):551-560.
62. Kerckhove N, Pereira B, Soriot-Thomas S, Alchaar H, Deleens R, Hieng VS, Serra E, Lanteri-Minet M, Arcagni P, Picard P et al: Efficacy and safety of a T-type calcium channel blocker in patients with neuropathic pain: A proof-of-concept, randomized, double-blind and controlled trial. Eur J Pain 2018, 22(7):1321-1330.
63. Patel R, Montagut-Bordas C, Dickenson AH: Calcium channel modulation as a target in chronic pain control. Br J Pharmacol 2018, 175(12):2173-2184.
64. Hogan QH: Labat lecture: the primary sensory neuron: where it is, what it does, and why it matters. Regional anesthesia and pain medicine 2010, 35(3):306-311.
65. Pfirrmann CW, Oberholzer PA, Zanetti M, Boos N, Trudell DJ, Resnick D, Hodler J: Selective nerve root blocks for the treatment of sciatica: evaluation of injection site and effectiveness--a study with patients and cadavers. Radiology 2001, 221(3):704-711.
66. Fischer G, Kostic S, Nakai H, Park F, Sapunar D, Yu H, Hogan Q: Direct injection into the dorsal root ganglion: technical, behavioral, and histological observations. Journal of neuroscience methods 2011, 199(1):43-55.
67. Pomonis JD, Boulet JM, Gottshall SL, Phillips S, Sellers R, Bunton T, Walker K: Development and pharmacological characterization of a rat model of osteoarthritis pain. Pain 2005, 114(3):339-346.